Pharmaceutical compounds

Details for Australian Patent Application No. 2006207325 (hide)

Owner Astex Therapeutics Limited

Inventors Thompson, Kyla Merriom; Curry, Jayne Elizabeth; Squires, Matthew Simon; Wyatt, Paul Graham; Thompson, Neil Thomas; Lyons, John Francis

Agent Davies Collison Cave

Pub. Number AU-B-2006207325

PCT Pub. Number WO2006/077428

Priority 60/645,974 21.01.05 US; 60/646,003 21.01.05 US; 60/646,001 21.01.05 US; 60/645,988 21.01.05 US; 60/646,216 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 16 August 2012

International Classifications

A61K 31/415 - 1,2-Diazoles

A61K 31/135 - having aromatic rings, e.g. methadone

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/195

A61K 31/255

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61K 31/4188

A61K 31/4196 - 1,2,4-Triazoles

A61K 31/4535

A61K 31/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/5685

A61K 31/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077428 Priority application(s): WO2006/077428

16 August 2012 Application Accepted

  Published as AU-B-2006207325

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207326-Anthelmintic composition

2006207323-4- (2, 6-dichlorobenzoylamino) - lH-pyrazole-3 -carboxylic acid piperidin4 -ylamid acid addition salts as kinase inhibitors